Cargando…
Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect
In this case report, we present a patient who suffered ceftaroline-associated encephalopathy, while receiving ceftaroline for acute bacterial skin and skin structure infections (aBSSSIs) that resolved after cessation of the suspected agent. We recommend close monitoring for encephalopathy in patient...
Autores principales: | Srinivasan, Aswin, Bennie, Blake, Viroliya, Krina, Kesavan, Ramesh, Sarva, Siva T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169127/ https://www.ncbi.nlm.nih.gov/pubmed/34094755 http://dx.doi.org/10.7759/cureus.14795 |
Ejemplares similares
-
Parvovirus Reactivation in COVID-19
por: Lai, Peter Y, et al.
Publicado: (2021) -
A Comparison of ICU Mortality Scoring Systems Applied to COVID-19
por: Monk, Muhammad, et al.
Publicado: (2023) -
A Case of Ceftaroline-Associated Thrombocytopenia
por: Jagadish, Ashwin, et al.
Publicado: (2023) -
Endogenous Endophthalmitis From Methicillin-Resistant Staphylococcus aureus Bacteremia Treated With Ceftaroline
por: Ho, Daniel, et al.
Publicado: (2022) -
Ceftaroline Fosamil as an Alternative for a Severe Methicillin-resistant Staphylococcus aureus Infection: A Case Report
por: Jilani, Talha N, et al.
Publicado: (2018)